Es gab 50 kürzliche Insider-Transaktionen für Bolt Biotherapeutics, Inc. (BOLT), darunter 31 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.07M und die gesamten Insider-Verkäufe auf $479.25K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Yonehiro Grant, Quinn William P., Nemec Sarah. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — BOLT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-28 |
Yonehiro Grant |
Chief Operating Officer |
RSU-Zuteilung |
10,000 |
$6.71 |
$67.1K |
10,000 |
| 2026-01-28 |
Quinn William P. |
President, CEO and CFO |
RSU-Zuteilung |
20,000 |
$6.71 |
$134.2K |
20,000 |
| 2026-01-28 |
Nemec Sarah |
Senior VP, Finance and Pao |
RSU-Zuteilung |
8,000 |
$6.71 |
$53.68K |
8,000 |
| 2025-12-12 |
Laporte Kathleen |
Director |
Aktienrückgabe |
1,250 |
$32.60 |
$40.75K |
- |
| 2025-12-12 |
Onetto Nicole |
Director |
Aktienrückgabe |
611 |
$60.60 |
$37.03K |
- |
| 2025-12-12 |
O'callaghan Brian |
Director |
Aktienrückgabe |
1,100 |
$15.36 |
$16.9K |
- |
| 2025-12-12 |
Yonehiro Grant |
Chief Operating Officer |
Aktienrückgabe |
7,749 |
$14.60 |
$113.15K |
- |
| 2025-12-12 |
Dupont Jakob |
Director |
Aktienrückgabe |
849 |
$13.60 |
$11.54K |
- |
| 2025-12-12 |
Quinn William P. |
President, CEO and CFO |
RSU-Zuteilung |
3,927 |
$5.44 |
$21.36K |
3,927 |
| 2025-12-12 |
Berner Laura |
Director |
Aktienrückgabe |
1,250 |
$32.60 |
$40.75K |
- |
| 2025-12-12 |
Nemec Sarah |
Senior VP, Finance and Pao |
Aktienrückgabe |
2,199 |
$61.60 |
$135.46K |
- |
| 2025-12-05 |
Quinn William P. |
President, CEO and CFO |
Informierter Kauf |
125 |
$4.61 |
$575.88 |
2,313 |
| 2025-12-05 |
Nemec Sarah |
Senior VP, Finance and Pao |
Informierter Kauf |
125 |
$4.61 |
$575.88 |
1,415 |
| 2025-05-01 |
Yonehiro Grant |
Chief Operating Officer |
RSU-Zuteilung |
350,000 |
$0.35 |
$122.85K |
350,000 |
| 2025-05-01 |
Dupont Jakob |
Director |
RSU-Zuteilung |
20,000 |
$0.35 |
$7.02K |
20,000 |
| 2025-05-01 |
Quinn William P. |
President, CEO and CFO |
RSU-Zuteilung |
700,000 |
$0.35 |
$245.7K |
700,000 |
| 2025-05-01 |
Nemec Sarah |
Senior VP, Finance and Pao |
RSU-Zuteilung |
226,000 |
$0.35 |
$79.33K |
226,000 |
| 2024-12-16 |
Quinn William P. |
President, CEO and CFO |
Informierter Kauf |
2,500 |
$0.50 |
$1.24K |
41,272 |
| 2024-12-16 |
Nemec Sarah |
Senior VP, Finance and Pao |
Informierter Kauf |
2,500 |
$0.50 |
$1.24K |
16,633 |
| 2024-09-03 |
Dupont Jakob |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-03 |
Dupont Jakob |
Director |
RSU-Zuteilung |
16,984 |
$0.68 |
$11.55K |
16,984 |
| 2024-07-23 |
Yonehiro Grant |
Chief Operating Officer |
RSU-Zuteilung |
155,000 |
$0.73 |
$113.17K |
155,000 |
| 2024-07-23 |
Quinn William P. |
President, CEO and CFO |
RSU-Zuteilung |
440,000 |
$0.73 |
$321.24K |
440,000 |
| 2024-07-23 |
Nemec Sarah |
VP, Finance and Pao |
RSU-Zuteilung |
50,000 |
$0.73 |
$36.51K |
50,000 |
| 2024-06-12 |
Laporte Kathleen |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
Onetto Nicole |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
Healy James |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
Shah Mahendra |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
O'callaghan Brian |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
Lee Frank D. |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-12 |
Berner Laura |
Director |
RSU-Zuteilung |
22,000 |
$0.77 |
$16.9K |
22,000 |
| 2024-06-06 |
Quinn William P. |
President, CEO and CFO |
Informierter Kauf |
2,500 |
$0.64 |
$1.59K |
38,772 |
| 2024-06-06 |
Nemec Sarah |
Senior VP, Finance and Pao |
Informierter Kauf |
2,500 |
$0.64 |
$1.59K |
13,863 |
| 2024-05-15 |
Nemec Sarah |
Principal Accounting Officer |
Veräußerung |
31,800 |
$1.27 |
$40.39K |
- |
| 2024-03-04 |
Yonehiro Grant |
Chief Business Officer |
RSU-Zuteilung |
235,000 |
$1.27 |
$298.45K |
235,000 |
| 2024-03-04 |
Schatzman Randall C |
Chief Executive Officer |
RSU-Zuteilung |
654,000 |
$1.27 |
$830.58K |
235,000 |
| 2024-03-04 |
Quinn William P. |
Chief Financial Officer |
RSU-Zuteilung |
235,000 |
$1.27 |
$298.45K |
235,000 |
| 2024-03-04 |
Perez Edith A. |
Chief Medical Officer |
RSU-Zuteilung |
235,000 |
$1.27 |
$298.45K |
235,000 |
| 2023-12-31 |
Yonehiro Grant |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-31 |
Schatzman Randall C |
Chief Executive Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-31 |
Perez Edith A. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-12 |
Quinn William P. |
Chief Financial Officer |
Informierter Kauf |
7,500 |
$0.95 |
$7.13K |
36,272 |
| 2023-12-06 |
Quinn William P. |
Chief Financial Officer |
Informierter Kauf |
2,500 |
$0.78 |
$1.96K |
28,772 |
| 2023-11-30 |
Engleman Edgar |
Director |
Informierter Verkauf |
14,934 |
$0.86 |
$12.81K |
251,522 |
| 2023-11-29 |
Engleman Edgar |
Director |
Informierter Verkauf |
3,131 |
$0.91 |
$2.84K |
266,456 |
| 2023-11-21 |
Engleman Edgar |
Director |
Informierter Verkauf |
236 |
$0.90 |
$212.73 |
269,587 |
| 2023-11-21 |
Vivo Capital Viii, Llc |
10 Percent Owner |
Informierter Verkauf |
1,457 |
$0.90 |
$1.31K |
111,662 |
| 2023-11-20 |
Engleman Edgar |
Director |
Informierter Verkauf |
3,792 |
$0.92 |
$3.49K |
269,823 |
| 2023-11-20 |
Vivo Capital Viii, Llc |
10 Percent Owner |
Informierter Verkauf |
23,443 |
$0.92 |
$21.57K |
113,119 |
| 2023-11-17 |
Engleman Edgar |
Director |
Informierter Verkauf |
1,134 |
$0.93 |
$1.05K |
273,615 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
